Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 10, 2013, Pages 1212-1216

  Voudoukis, Evangelos ^a   Karmiris, Konstantinos ^a   Oustamanolakis, Pantelis ^b   Theodoropoulou, Angeliki ^a   Sfiridaki, Aekaterini ^a   Paspatis, Gregorios A ^a   Koutroubakis, Ioannis E ^b  

^a Venizelion General Hospital   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOSALICYLIC ACID; AZATHIOPRINE; C REACTIVE PROTEIN; CYANOCOBALAMIN; FERRITIN; FOLIC ACID; HEMOGLOBIN; METHOTREXATE; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENTERITIS; ERYTHROCYTE; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HUMAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE VOLUME; THROMBOCYTOSIS; ULCERATIVE COLITIS;

ADULT; ANEMIA, IRON-DEFICIENCY; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; ERYTHROCYTE INDICES; FEMALE; FERRITINS; HEMATOCRIT; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; PLATELET COUNT; SEVERITY OF ILLNESS INDEX; THROMBOCYTOSIS;

EID: 84883654273     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328363e354     Document Type: Article

References (28)

1. Gasche C. Anemia in IBD: the overlooked villain. Inflamm Bowel Dis 2000; 6:142-150.
2. Oustamanolakis P, Koutroubakis IE, Messaritakis I, Kefalogiannis G., Niniraki M, Kouroumalis EA Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease. J Crohns Colitis 2011; 5:295-300.
3. Collins CE, Cahill MR, Newland A.C., Rampton DS Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994; 106:840-845. (Pubitemid 24109268)
4. Koutroubakis IE, Theodoropoulou A, Xidakis C., Sfiridaki A, Notas G, Kolios G., et al. Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2004; 16:1147-1152. (Pubitemid 39488786)
5. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos S.P., Kosmadaki MG, Koutroubakis IE, Kouroumalis EA Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 2001; 96:776-781. (Pubitemid 32240730)
6. Järemo P, Sandberg-Gertzen H. Platelet density and size in inflammatory bowel disease. Thromb Haemost 1996; 75:560-561. (Pubitemid 26138260)
7. Griesshammer M, Bangerter M, Sauer T., Wennuer R, Bergmann L, Heimpel H. Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. J Intern Med 1999; 245:295-300. (Pubitemid 29132973)
8. Stange EF, Travis SP, Vermeire S, Beglinger C., Kupcinkas L, Geboes K, et al European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006; 55:i1-i15. (Pubitemid 43268290)
9. Stange EF, Travis SP, Vermeire S, Reinisch W., Geboes K, Barakauskiene A, et al European evidence based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis 2008; 2:1-23. (Pubitemid 351179487)
10. Silverberg MS, Satsangi J, Ahmad T., Arnott ID, Bernstein CN, Brant SR, et al Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl A):5-36.
11. Best WR, Becktel JM, Singleton J.W., Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70:439-444.
12. Walmsley RS, Ayres RC, Pounder R.E., Allan RN A simple clinical colitis activity index. Gut 1998; 43:29-32. (Pubitemid 28335486)
13. WHO, UNICEF, UNU. Iron deficiency anemia: assessment, prevention and control. A guide for programme managers. WHO reference number: WHO/NHD/01.3. Geneva: WHO publications 2001; p. 33.
14. Schafer AI. Thrombocytosis. N Engl J Med 2004; 350:1211-1219. (Pubitemid 38339365)
15. Cerutti A, Custodi P, Mduranti, Cazzola M, Balduini CL. Circulating thrombopoietin in reactive conditions behaves like an acute phase reactant. Clin Lab Haematol 1999; 21:271-275. (Pubitemid 29444743)
16. Kaser A, Brandacher G, Steurer W., Kaser S, Offner FA, Zoller H, et al Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 2001; 98:2720-2725.
17. Heits F, Stahl M, Ludwig D., Stange EF, Jelkmann W. Elevated serum thrombopoietin and interleukin-6 concentrations in thrombocytosis associated with inflammatory bowel disease. J Interferon Cytokine Res 1999; 19:757-760. (Pubitemid 29379818)
18. Adamson JW. The anemia of inflammation/malignancy: mechanisms and management. Hematology Am Soc Hematol Educ Program 2008; 1:159-165.
19. Infusino I, Braga F, Dolci A., Panteghini M. Soluble transferrin receptor (sTfR) and sTfR/log ferritin index for the diagnosis of iron-deficiency anemia. A meta-analysis. Am J Clin Pathol 2012; 138:642-649.
20. Oustamanolakis P, Koutroubakis IE, Kouroumalis EA Diagnosing anemia in inflammatory bowel disease: beyond the established markers. J Crohns Colitis 2011; 5:381-391.
21. Gasche C, Berstad A, Befrits R., Beglinger C, Dignass A, Erichsen K., et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13:1545-1553.
22. Oustamanolakis P, Koutroubakis IE, Messaritakis I, Niniraki M., Kouroumalis EA Soluble transferrin receptor-ferritin index in the evaluation of anemia in inflammatory bowel disease: a case-control study. Ann Gastroenterol 2011; 24:110-116.
23. Oustamanolakis P, Koutroubakis IE Soluble transferrin receptor-ferritin index is the most efficient marker for the diagnosis of iron deficiency anemia in patients with IBD. Inflamm Bowel Dis 2011; 17:158-159.
24. Kadikoylu G, Yavasoglu I, Bolaman Z., Senturk T. Platelet parameters in women with iron deficiency anemia. J Natl Med Assoc 2006; 98:398-402. (Pubitemid 43352530)
25. Kuku I, Kaya E, Yologlu S., Gokdeniz R, Baydin A. Platelet counts in adults with iron deficiency anemia. Platelets 2009; 20:401-405.
26. Choi SI, Simone JV, Jackson CW Megakaryocytopoiesis in experimental iron deficiency anemia. Blood 1974; 43:111-120.
27. Bilic E, Bilic E. Amino acid sequence homology of thrombopoietin and erythropoietin may explain thrombocytosis in children with iron deficiency anemia. J Pediatr Hematol Oncol 2003; 25:675-676. (Pubitemid 36959439)
28. Kulnigg-Dabsch S., Evstatiev R, Dejaco C., Gasche C. Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia. PLoS One 2012; 7:e34520.